Container Store Group And 2 Other Penny Stocks Insiders Are Buying - Nuo Therapeutics (OTC:AURX), RENN Fu

The Dow Jones closed lower by around 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Container Store Group

The Trade: The Container Store Group, Inc. (NYSE:TCS) CFO Jeffrey A Miller acquired a total of 3,860 shares an average price of $2.60. To acquire these shares, it cost around $10,023.
What’s Happening: Container Store reported worse-than-expected first-quarter financial results..
What Container Store Group Does: The Container Store Group Inc is a U.S. based specialty retailer of storage and organization products and solutions. It offers a collection of multifunctional and customizable storage and organization solutions.

Nuo Therapeutics

The Trade: Nuo Therapeutics, Inc. (OTC:AURX) 10% owner Charles E Sheedy acquired a total of 62,500 shares at an average price of $2.00. The insider spent around $125,000.
What’s Happening: The company’s stock declined 22% over the past month.
What Nuo Therapeutics Does: Nuo Therapeutics Inc is a regenerative therapies company focused on developing and marketing products for chronic wound care primarily within the U.S. Company's commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing.

RENN Fund

The Trade: RENN Fund, Inc. (NYSE:RCG) CEO and President Murray Stahl acquired a total of 419 shares at an average price of $1.85. To acquire these shares, it cost around $775.
What’s Happening: RENN Fund shares have gained around 2% since the start of the year.
What RENN Fund Does: RENN Fund Inc is active in the financial services domain. It is a closed-end management investment company formed with the objective of providing long-term capital appreciation by investing substantially in privately placed convertible and equity securities of emerging growth companies traded on the United States securities exchanges.

Check This Out: Wall Street's Most Accurate Analysts Say Hold These 3 Consumer Stocks Delivering High-Dividend Yields

Don’t forget to check out our premarket coverage here

AURXNuo Therapeutics Inc

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.